A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Recruiting

Phase 1

INCA036873A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Sponsor:

Incyte Corporation

Code:

NCT07195916

Conditions

Solid Tumors

Hematologic Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INCA036873

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-20. This information was provided to ClinicalTrials.gov by Incyte Corporation on 2026-05-04.